The Attractiveness of Investing In Disc Medicine Inc (IRON) is Growing

Roman Campbell

Disc Medicine Inc’s filing revealed that its Chief Operating Officer Yu Jonathan Yen-Wen unloaded Company’s shares for reported $2.54 million on Nov 11 ’25. In the deal valued at $84.70 per share,30,000 shares were sold. As a result of this transaction, Yu Jonathan Yen-Wen now holds 40,555 shares worth roughly $3.82 million.

Then, JONATHAN YU bought 30,000 shares, generating $2,507,400 in total proceeds.

Before that, AI DMI LLC sold 744,047 shares. Disc Medicine Inc shares valued at $59,873,462 were divested by the 10% Owner at a price of $80.47 per share. As a result of the transaction, AI DMI LLC now holds 2,814,379 shares, worth roughly $264.86 million.

A number of analysts have revised their coverage, including Truist’s analysts, who began to cover the stock in late July with a ‘”a Buy”‘ rating.

Price Performance Review of IRON

On Monday, Disc Medicine Inc [NASDAQ:IRON] saw its stock jump 1.63% to $94.11. Over the last five days, the stock has gained 4.97%. Disc Medicine Inc shares have risen nearly 50.46% since the year began. Nevertheless, the stocks have risen 48.44% over the past one year. While a 52-week high of $95.95 was reached on 11/24/25, a 52-week low of $30.82 was recorded on 04/09/25.

Levels Of Support And Resistance For IRON Stock

The 24-hour chart illustrates a support level at 92.83, which if violated will result in even more drops to 91.55. On the upside, there is a resistance level at 96.25. A further resistance level may holdings at 98.40.

How much short interest is there in Disc Medicine Inc?

A steep rise in short interest was recorded in Disc Medicine Inc stocks on 2025-10-31, growing by 0.23 million shares to a total of 2.87 million shares. Yahoo Finance data shows the prior-month short interest on 2025-09-30 was 2.64 million shares. There was a rise of 7.97%, which implies that there is a positive sentiment for the stock.

The most recent change occurred on February 27, 2025 when TD Cowen began covering the stock and recommended ‘”a Buy”‘ rating.

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.